JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.17% |
| 2 | Financials | 10.11% |
| 3 | Consumer Discretionary | 9.84% |
| 4 | Healthcare | 7.97% |
| 5 | Communication Services | 6.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
ANI Pharmaceuticals
ANIP
$1.72B
| $14.8M | ﹤0.01% |
268,050
-286,785
| -52% | -$16.5M |
|
2277
Rhythm Pharmaceuticals
RYTM
$8.1B
| $14.8M | ﹤0.01% |
264,585
+182,993
| +224% | +$10.1M |
|
|
GRFS
2278
Grifois
GRFS
$5.4B
| $14.8M | ﹤0.01% |
1,988,043
-14,468
| -0.7% | -$121K |
|
2279
iShares ESG Advanced Universal USD Bond ETF
EUSB
$713M
| $14.8M | ﹤0.01% |
347,847
-17,808
| -5% | -$769K |
|
2280
Schwab US Mid-Cap ETF
SCHM
$15.3B
| $14.8M | ﹤0.01% |
533,200
-26,372
| -5% | -$751K |
|
|
B
2281
PUT
Barrick Mining
B
$67.3B
| $14.8M | ﹤0.01% |
951,800
+674,800
| +244% | +$12.3M |
|
2282
FNB Corp
FNB
$6.86B
| $14.7M | ﹤0.01% |
996,865
+9,781
| +1% | +$150K |
|
2283
Vanguard Energy ETF
VDE
$10.4B
| $14.7M | ﹤0.01% |
121,435
-2,046
| -2% | -$261K |
|
2284
Treace Medical Concepts
TMCI
$309M
| $14.7M | ﹤0.01% |
1,977,219
+714,984
| +57% | +$4.78M |
|
2285
Sumitomo Mitsui Financial
SMFG
$167B
| $14.7M | ﹤0.01% |
1,015,206
-354,744
| -26% | -$4.87M |
|
2286
Dimensional US Small Cap ETF
DFAS
$15.9B
| $14.7M | ﹤0.01% |
225,839
+31,889
| +16% | +$2.13M |
|
|
AKRO
2287
DELISTED
Akero Therapeutics
AKRO
| $14.7M | ﹤0.01% |
528,207
+40,161
| +8% | +$1.22M |
|
2288
Amer Sports
AS
$19.3B
| $14.7M | ﹤0.01% |
524,072
+522,512
| +33,494% | +$11.5M |
|
2289
Hilltop Holdings
HTH
$2.25B
| $14.6M | ﹤0.01% |
511,418
+30,861
| +6% | +$964K |
|
2290
PUT
Rivian
RIVN
$22.9B
| $14.6M | ﹤0.01% |
1,100,300
+893,000
| +431% | +$10.3M |
|
2291
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.37B
| $14.6M | ﹤0.01% |
544,699
+244,112
| +81% | +$7.63M |
|
2292
Dimensional US Core Equity Market ETF
DFAU
$12.9B
| $14.6M | ﹤0.01% |
360,580
+16,471
| +5% | +$673K |
|
2293
International Seaways
INSW
$4.58B
| $14.6M | ﹤0.01% |
406,197
+10,142
| +3% | +$432K |
|
|
BNY
2294
CALL
Bank of New York Mellon
BNY
$111B
| $14.6M | ﹤0.01% |
190,000
| – | – |
|
2295
PUT
Twilio
TWLO
$37.9B
| $14.6M | ﹤0.01% |
135,000
+95,000
| +238% | +$8.68M |
|
2296
Vontier
VNT
$4.52B
| $14.6M | ﹤0.01% |
399,334
-14,503
| -4% | -$535K |
|
2297
Ionis Pharmaceuticals
IONS
$9.39B
| $14.5M | ﹤0.01% |
415,919
-152,987
| -27% | -$5.72M |
|
2298
Progress Software
PRGS
$1.79B
| $14.5M | ﹤0.01% |
222,891
-294,689
| -57% | -$19.7M |
|
2299
iShares 10+ Year Investment Grade Corporate Bond ETF
IGLB
$2.8B
| $14.5M | ﹤0.01% |
293,909
-233,869
| -44% | -$12M |
|
2300
CALL
US Bancorp Series B Preferred Stock
USB.PRH
$743M
| $14.5M | ﹤0.01% |
302,700
+301,700
| +30,170% | +$6.71M |
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 510 new, 3,353 increased, 2,466 reduced and 523 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 510 new positions and closed 523 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.